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Progress in dialysis therapy has widely improved the prognosis of chronically ill dialysis patients, but kidney
transplantation is particularly known to improve patient prognosis significantly. However, the shortage of organ
transplant donors remains a global issue. Additionally, the donor’s pre-transplant serum creatinine (sCr) is a
known indicator of post-transplant kidney function, but the time point of sCr measurement has not been suffi-
ciently reported. In this study, we defined 2 time points of pre-transplantation donor sCr measurement: (1) sCr
taken just before surgical resection (final sCr) and (2) sCr taken on admission to the hospital (sCrmin). Thus, we in-
vestigated the level of pre-transplantation sCr in the donor and post-transplantation renal function in the trans-
plant patients.
In this single-center study, we included 157 patients who underwent donated kidney transplantation between
January 1995 and December 2015 at the Department of Surgery, Kidney Center, Tokyo Women’s Medical Uni-
versity Hospital. We compared the postoperative renal function with sCrmin and final sCr before transplantation.
Donor sCr may be affected by acute renal failure or acute tubular necrosis under various situations, such as re-
duction in organ blood flow in the period from admission to organ donation. Therefore, donor sCr was highly
likely to change depending on the time point in the treatment.
The comparison showed a significant difference between the levels of sCr and postoperative renal function (sCr
of more than 1.0 mg/dl and lower). However, there was no correlation between higher final sCr and lower postop-
erative renal function. We believed that donor sCrmin reflected the original renal function of the donor, and we ob-
tained a significant difference in the multivariate analysis to designate it as a prognostic factor.
We concluded that that sCrmin values are a better reflection of the donor’s original renal function as compared to fi-
nal sCr. Our findings are significant because they address the current research gap on preoperarive sCr values
and prove that sCr taken on admission can accurately predict the donor’s post-transplant kidney health, which
could lead to better post-operative care for the donor.
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the Kidney Donor Risk Index（KDRI），KDRIを基に

















1995年 1月から 2015年 12月の間に当科におい













































ついては，death with functioning graftの場合を除
いて比較するため，死亡日を移植腎機能喪失（graft
loss）とは扱わず，死亡日をもって観察期間を打ち切
り（death censored graft survival）とした．また，
Table 2～4では条件ごとに反復測定分散分析（re-







Donated due to brain death/cardiac arrest 29/128
Recipient sex (male/female) 93/64
Recipient age (years) 54.45 ± 15.60
Donor sex (male/female) 93/64
Donor age (years) 47.11 ± 17.29
Warm ischemic time (min) 6.19 ± 10.41
Total ischemic time (min) 576.64 ± 299.81
Number of HLA-AB mismatches 2.01 ± 0.95
Number of HLA-DR mismatches 0.62 ± 0.78
HLA: human leukocyte antigen.
Table　2　Post-transplantation changes in sCr according to the WIT period and the TIT 
period when WIT ≥ 31 minutes.
After 1 month After 3 months After 6 months After 12 months
WIT
≤ 30 min 2.93 ± 0.51 2.10 ± 0.25 1.69 ± 0.23 1.78 ± 0.28
≥ 31 min 2.82 ± 1.04 2.93 ± 2.45 3.49 ± 1.57 2.64 ± 1.32
WIT/TIT
≥ 31 min/< 12 h 1.29 ± 0.35 1.05 ± 0.65 1.33 1.34
≥ 31 min/≥ 12 h 7.45 ± 1.46 4.80 ± 2.04 3.92 ± 1.29 3.07 ± 1.22
Repeated measures ANOVA p < 0.001.
Table　3　Differences in post-transplantation changes in sCr according to donor 
age.
Donor age After 1 month After 3 months After 6 months After 12 months
≤ 30 yrs. 2.06 ± 0.63 1.64 ± 1.34 1.45 ± 0.23 1.48 ± 0.53
31-60 yrs. 2.82 ± 0.47 2.14 ± 0.23 1.72 ± 0.30 1.80 ± 0.36
≥ 61 yrs. 3.86 ± 0.68 2.43 ± 0.40 2.30 ± 0.91 2.11 ± 0.50
Repeated measures ANOVA p < 0.001.
Table 4　Differences in post-transplantation changes in sCr due to minimum donor sCr (sCrmin) and final donor sCr (final 
sCr).
Group NO. After 1 year After 2 years After 3 years After 4 years After 5 years
sCrmin (mg/dl) ＊
　≤ 1 (n = 105) 1.46 ± 0.38 1.36 ± 0.42 1.33 ± 0.38 1.75 ± 0.71 1.76 ± 1.46
　> 1 (n = 31) 1.96 ± 0.44 1.79 ± 0.50 1.64 ± 0.52 2.05 ± 0.78 1.85 ± 1.20
final sCr (mg/dl) ＊＊
　≤ 1 (n = 49) 1 1.75 ± 0.39 2.09 ± 1.11 2.04 ± 1.26 2.28 ± 1.16 1.75 ± 1.15
　1 <, ≤ 3 (n = 46) 2 1.90 ± 0.45 1.76 ± 0.39 1.74 ± 0.59 1.71 ± 0.61 2.51 ± 1.92
　3 <, ≤ 5 (n = 21) 3 1.79 ± 0.70 1.75 ± 0.86 1.50 ± 0.43 1.82 ± 0.87 1.55 ± 0.57
　5 < (n = 18) 4 2.17 ± 0.86 1.56 ± 0.48 1.49 ± 0.61 2.15 ± 1.06 1.79 ± 1.42













Figure 1 Graft survival rates of donated kidneys following transplantation.
The 1-year survival rate of the transplanted donated kidneys (n = 157) was 91.72% (n = 
145) and the 5-year survival rate was 85.49% (n = 118). 
Figure 2 Comparison of graft survival rates of kidneys from donors who died due to car-
diac arrest and brain death.
The 5-year graft survival rate was 96.55% for kidneys from brain dead donors (n = 29, 
mean observation period: 4.09 ± 1.37 years) and 84.12% for kidneys from cardiac arrest do-
nors (n = 128, mean observation period: 4.32 ± 1.47 years). 
Table　5　Stepwise and multivariate Cox regression to calculate the graft survival 
risk factor.
Univariate HR p-value Stepwise HR p-value
Donor age 1.055 0.0043 1.058 0.013
final sCr 1.029 0.69 NS
sCrmin 1.81 0.34 7.38 0.016
Donor cause of death: 
  celebrovascular disease 6.13 0.0038 4.90 0.016
Stepwise HR, adjusted hazard ratio of graft failure.
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Figure 3A Kidney graft survival rates according to recipient age.
The 5-year graft survival rate was 90.90% in recipients aged 30 years or younger (n = 22), 
85.0% in those aged 31-60 years, and 82.60% in those aged 61 years or older. 
Figure 3B Differences in kidney graft survival rates by donor age.
The 5-year graft survival rate was 100% in kidneys from donors aged 30 years or younger, 
85.60% for those aged 31-60 years, and 71.60% for those over the age of 61 years. The p-
value by log-rank test between donors aged 30 years or younger and 31-60 years is 0.021, 
between donors aged 30 years or younger and aged 61 years and older is < 0.001, and be-
tween donors aged 31-60 years and aged 61 years and older is 0.060. 
2．移植腎生着率
対象症例全体の移植腎生着率を示す．1年生着率












齢 30歳以下では 5年生着率は 100%，ドナー年齢 31
歳～60歳では 85.4%，ドナー年齢 61歳以上では
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Figure 4 Kidney graft survival rates by donor cause of death.
The 5-year graft survival rate was 76.20% in kidneys from donors whose cause of death 
was cerebrovascular disease. The p-value by log-rank test between the cerebrovascular 
disease group and other causes group was < 0.001. 
71.6%であり，log-rank testにおいて 30歳以下の群









は log-rank testにて p＜0.001と有意差を認めた．
次に，WITを 30分以下，31分以上の群に分けた

























び final sCrについて検討した．Table 4にドナーの
入院時における sCrminまたは final sCrごとの移植後
sCrを，移植後 5年までの推移を示したが，sCrmin
では sCrmin1と sCr＞1の群で有意差を認めており














Figure 5　Kidney graft survival rates according to (A) WIT period, (B) TIT period, (C) 































いて final sCr≧3.0 mg/dlの症例は 157症例中 40症
例存在していたが，その中で sCrmin≧1.5 mg/dlの症
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